Wesbanco Bank Inc Abb Vie Inc. Transaction History

Wesbanco Bank Inc

$2.89 Billion
Q3 2024

A detailed history of Wesbanco Bank Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Wesbanco Bank Inc holds 86,513 shares of ABBV stock, worth $15.8 Million. This represents 0.59% of its overall portfolio holdings.

Number of Shares

86,513

Previous 86,977 0.53%

Holding current value

$15.8 Million

Previous $14.9 Million 14.52%

% of portfolio

0.59%

Previous 0.57%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 11, 2024	SELL	$163.84 - $199.33 $76,021 - $92,489	-464 Reduced 0.53%	86,513 $17.1 Million
Q2 2024 Jul 11, 2024	SELL	$154.79 - $180.76 $263,916 - $308,195	-1,705 Reduced 1.92%	86,977 $14.9 Million
Q1 2024 Apr 23, 2024	BUY	$159.82 - $182.1 $8.53 Million - $9.72 Million	53,363 Added 151.09%	88,682 $16.1 Million
Q4 2023 Feb 16, 2024	SELL	$137.6 - $154.97 $8.56 Million - $9.64 Million	-62,181 Reduced 63.78%	35,319 $5.47 Million
Q3 2023 Dec 11, 2023	BUY	$133.59 - $154.65 $174,067 - $201,508	1,303 Added 1.35%	97,500 $14.5 Million
Q2 2023 Jul 13, 2023	SELL	$132.51 - $164.9 $156,626 - $194,911	-1,182 Reduced 1.21%	96,197 $13 Million
Q1 2023 Apr 21, 2023	SELL	$144.61 - $166.54 $51,336 - $59,121	-355 Reduced 0.36%	97,379 $15.5 Million
Q4 2022 Jan 18, 2023	BUY	$138.31 - $165.87 $8.6 Million - $10.3 Million	62,169 Added 174.8%	97,734 $15.8 Million
Q3 2022 Oct 13, 2022	SELL	$134.21 - $153.93 $8.56 Million - $9.82 Million	-63,801 Reduced 64.21%	35,565 $4.77 Million
Q2 2022 Jul 18, 2022	SELL	$137.62 - $174.96 $244,688 - $311,078	-1,778 Reduced 1.76%	99,366 $15.2 Million
Q1 2022 Apr 25, 2022	SELL	$131.98 - $163.75 $832,529 - $1.03 Million	-6,308 Reduced 5.87%	101,144 $16.4 Million
Q4 2021 Feb 02, 2022	SELL	$107.43 - $135.93 $1.39 Million - $1.75 Million	-12,893 Reduced 10.71%	107,452 $14.5 Million
Q3 2021 Oct 12, 2021	BUY	$106.4 - $120.78 $1.33 Million - $1.51 Million	12,531 Added 11.62%	120,345 $13 Million
Q2 2021 Aug 09, 2021	SELL	$105.21 - $117.21 $171,807 - $191,403	-1,633 Reduced 1.49%	107,814 $12.1 Million
Q1 2021 May 06, 2021	SELL	$102.3 - $112.62 $1.79 Million - $1.97 Million	-17,498 Reduced 13.78%	109,447 $11.8 Million
Q3 2020 Nov 13, 2020	SELL	$85.91 - $100.83 $111,683 - $131,079	-1,300 Reduced 1.01%	126,945 $11.1 Million
Q2 2020 Jul 14, 2020	BUY	$73.37 - $98.18 $3.96 Million - $5.3 Million	54,010 Added 72.76%	128,245 $12.6 Million
Q1 2020 May 12, 2020	BUY	$64.5 - $97.79 $304,827 - $462,155	4,726 Added 6.8%	74,235 $5.66 Million
Q4 2019 Feb 13, 2020	BUY	$72.13 - $90.25 $41,330 - $51,713	573 Added 0.83%	69,509 $6.15 Million
Q3 2019 Nov 07, 2019	BUY	$62.98 - $75.72 $229,562 - $275,999	3,645 Added 5.58%	68,936 $5.22 Million
Q2 2019 Aug 13, 2019	BUY	$65.7 - $83.98 $45,727 - $58,450	696 Added 1.08%	65,291 $4.75 Million
Q1 2019 May 09, 2019	BUY	$77.14 - $90.79 $702,205 - $826,461	9,103 Added 16.4%	64,595 $5.21 Million
Q4 2018 Feb 05, 2019	SELL	$77.85 - $96.01 $6,305 - $7,776	-81 Reduced 0.15%	55,492 $5.12 Million
Q3 2018 Nov 09, 2018	SELL	$88.91 - $98.84 $121,628 - $135,213	-1,368 Reduced 2.4%	55,573 $5.26 Million
Q2 2018 Aug 08, 2018	BUY	$89.78 - $106.23 $41,927 - $49,609	467 Added 0.83%	56,941 $5.28 Million
Q1 2018 May 18, 2018	BUY	$92.01 - $123.21 $2.15 Million - $2.88 Million	23,377 Added 70.63%	56,474 $5.35 Million
Q4 2017 Feb 01, 2018	SELL	$89.56 - $98.21 $2.26 Million - $2.47 Million	-25,188 Reduced 43.22%	33,097 $3.2 Million
Q3 2017 Nov 02, 2017	BUY	$69.85 - $89.22 $319,703 - $408,359	4,577 Added 8.52%	58,285 $5.18 Million
Q2 2017 Aug 08, 2017	BUY	N/A	53,708	53,708 $3.89 Million

Others Institutions Holding ABBV

# of Institutions

3,849

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $324B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wesbanco Bank Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wesbanco Bank Inc with notifications on news.

Account

Wesbanco Bank Inc Abb Vie Inc. Transaction History